Search

Your search keyword '"Shickh, Salma"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Shickh, Salma" Remove constraint Author: "Shickh, Salma"
129 results on '"Shickh, Salma"'

Search Results

1. “I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening

3. Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testing

4. “I don’t need any more unknowns hanging over my head”: Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing

5. A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings

15. Theory‐based behavior change intervention to increase uptake of risk‐reducing salpingo‐oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial

16. “I don’t need any more unknowns hanging over my head”: Cancer patients’ views on variants of uncertain significance and low/moderate risk results from genomic sequencing

17. Development of patient “profiles” to tailor counseling for incidental genomic sequencing results

20. P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study

22. P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT

23. A model for the return and referral of all clinically significant secondary findings of genomic sequencing

24. How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey

25. P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review

27. P382: Professionals’ perspectives on the use of digital tools to support patient recontact in clinical genetics

28. P543: Comparing the analytical performance of exome sequencing and traditional panel testing in a cancer population

32. “Doctors shouldn’t have to cheat the system”: Clinicians’ real-world experiences of the utility of genomic sequencing

33. A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings

34. Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery

35. Patient-facing digital tools for delivering genetic services: a systematic review.

36. eP502: How will returning variants of uncertain significance impact healthcare use? A cross-sectional survey

37. eP392: A comprehensive genomic test reporting structure for communicating cancer and incidental findings

39. eP299: Genetics adviser: The development and usability testing of a new patient-centered digital health application to support clinical genomic testing

40. “I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening

41. The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care

42. "Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.

43. Widening the lens of actionability: A qualitative study of primary care providers’ views and experiences of managing secondary genomic findings

44. Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings

45. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study

46. Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial

47. Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial

48. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study.

49. Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial

50. Quality of life drives patients’ preferences for secondary findings from genomic sequencing

Catalog

Books, media, physical & digital resources